Chinese Journal of Tissue Engineering Research ›› 2019, Vol. 23 ›› Issue (30): 4780-4786.doi: 10.3969/j.issn.2095-4344.1421

Previous Articles     Next Articles

Biphasic calcium phosphate scaffolds modified with collagen based on three-dimensional printing technology

Zhang Haige1, Suo Hairui1,2, Wang Ling1,2, Xu Mingen1,2
  

  1. 1Zhejiang Provincial Key Lab of Medical Information and Three-Dimensional Bio-Printing, Hangzhou Dianzi University, Hangzhou 310018, Zhejiang Province, China; 2College of Automation, Hangzhou Dianzi University, Hangzhou 310018, Zhejiang Province, China
  • Received:2019-05-13 Online:2019-10-28 Published:2019-10-28
  • Contact: Xu Mingen, MD, Professor, Zhejiang Provincial Key Lab of Medical Information and Three-Dimensional Bio-Printing, Hangzhou Dianzi University, Hangzhou 310018, Zhejiang Province, China; College of Automation, Hangzhou Dianzi University, Hangzhou 310018, Zhejiang Province, China
  • About author:Zhang Haige, Master candidate, Zhejiang Provincial Key Lab of Medical Information and Three-Dimensional Bio-Printing, Hangzhou Dianzi University, Hangzhou 310018, Zhejiang Province, China
  • Supported by:

    the National Natural Science Foundation of China, No. 61675059 (to WL); the National Key R & D Program of China, No. 2017YFC1103400 (to XME)

Abstract:

BACKGROUND: Three-dimensional collagen/biphasic calcium phosphate scaffolds with natural bone composition and mechanical strength, good surface activity and porous structure are a difficult point in bone tissue engineering research.
OBJECTIVE: To manufacture a three-dimensional porous bone tissue scaffold with high porosity, high mechanical strength and high surface biological activity.
METHODS: Biphasic calcium phosphate scaffold was manufactured by three-dimensional printing technology using hydroxyapatite and β-tricalcium phosphate with a mass ratio of 60∶40 as slurry. After high temperature sintering, the biphasic calcium phosphate scaffolds were coated with type I collagen at the concentrations of 0.5, 1.0 and 1.5 g/L. The optimal concentration of type I collagen solution was screened by apparent morphology, porosity, water absorption and mechanical properties to conduct cell experiments. Rat bone marrow mesenchymal stem cells were seeded onto biphasic calcium phosphate scaffolds and collagen/biphasic calcium phosphate scaffolds, separately. Cell viability was observed by Calcein-AM staining at 1 and 7 days; cell proliferation was detected by Alamar Blue method at 1, 3 and 7 days.
RESULTS AND CONCLUSION: When the mass concentration of type I collagen solution was 0.5 g/L, the collagen/biphasic calcium phosphate scaffold had good porosity and water absorption, the compressive strength was (4.99±0.15) MPa and the compressive modulus was (95.24±0.57) MPa, which met the mechanical strength requirements of natural cancellous bone. Therefore, the coating mass concentration 0.5 g/L was selected for cell experiments. Both kinds of scaffolds supported the growth of mesenchymal stem cells. After 7 days of culture, cells almost covered the surface of the collagen/biphasic calcium phosphate scaffold. Most of them were fusiform or star-shaped, and the cells were well stretched, arranged closely and adhered to form network structure. However, there was still no cell adhesion in some areas of the biphasic calcium phosphate scaffold. There was no significant difference in cell proliferation between two kinds of cells at 1 and 3 days (P > 0.05). The proliferation of cells cultured on the collagen/biphasic calcium phosphate scaffold for 7 days was faster than that cultured on the biphasic calcium phosphate scaffold for the same duration (P < 0.05). The results show that the coating of type I collagen solution can improve the biological activity of the biphasic calcium phosphate scaffold under the condition of ensuring porosity and high mechanical strength.

Key words: 3D printing, biphasic calcium phosphate, collagen, coating, cell viability, biological material, bone tissue, collagen/biphasic calcium phosphate scaffold, cell proliferation

CLC Number: